PetMed Express (PETS)
(Delayed Data from NSDQ)
$3.52 USD
+0.03 (0.86%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $3.53 +0.01 (0.28%) 6:10 PM ET
1-Strong Buy of 5 1
B Value C Growth A Momentum A VGM
Income Statements
Fiscal Year end for PetMed Express, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 281 | 257 | 273 | 309 | 284 |
Cost Of Goods | 202 | 186 | 195 | 219 | 203 |
Gross Profit | 79 | 71 | 78 | 90 | 81 |
Selling & Adminstrative & Depr. & Amort Expenses | 87 | 72 | 52 | 52 | 50 |
Income After Depreciation & Amortization | -8 | -1 | 26 | 38 | 31 |
Non-Operating Income | 2 | 3 | 1 | 2 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -6 | 2 | 27 | 39 | 34 |
Income Taxes | 1 | 1 | 6 | 9 | 8 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -7 | 0 | 21 | 31 | 26 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -7 | 0 | 21 | 31 | 26 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1 | 2 | 28 | 40 | 33 |
Depreciation & Amortization (Cash Flow) | 7 | 4 | 3 | 2 | 2 |
Income After Depreciation & Amortization | -8 | -1 | 26 | 38 | 31 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 20.40 | 20.34 | 20.36 | 20.12 | 20.06 |
Diluted EPS Before Non-Recurring Items | -0.33 | 0.37 | 1.08 | 1.52 | 1.29 |
Diluted Net EPS (GAAP) | -0.37 | 0.01 | 1.04 | 1.52 | 1.29 |
Fiscal Year end for PetMed Express, Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 67.95 | 66.50 | 65.32 | 71.00 | 78.24 |
Cost Of Goods | 49.98 | 48.33 | 47.43 | 50.94 | 55.72 |
Gross Profit | 17.97 | 18.18 | 17.88 | 20.06 | 22.53 |
SG&A, R&D, and Dept/Amort Expenses | 13.58 | 20.70 | 20.96 | 20.50 | 24.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | 4.39 | -2.52 | -3.08 | -0.44 | -2.13 |
Non-Operating Income | 0.33 | -0.49 | 0.43 | 0.82 | 1.13 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 4.71 | -3.01 | -2.65 | 0.38 | -1.00 |
Income Taxes | 0.96 | 1.47 | -0.62 | 0.45 | -0.12 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 3.75 | -4.48 | -2.03 | -0.07 | -0.89 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 3.75 | -4.48 | -2.03 | -0.07 | -0.89 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 20.94 | 20.44 | 20.43 | 20.38 | 20.33 |
Diluted EPS Before Non-Recurring Items | 0.18 | -0.25 | -0.10 | 0.00 | 0.00 |
Diluted Net EPS (GAAP) | 0.18 | -0.23 | -0.10 | 0.00 | -0.04 |